Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
cytokine immunotherapy agent |
| gptkbp:activeIngredient |
gptkb:interleukin-2
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| https://www.w3.org/2000/01/rdf-schema#label |
recombinant interleukin-2
|
| gptkbp:macromoleculeType |
gptkb:IL-2_receptor
|
| gptkbp:marketedAs |
gptkb:aldesleukin
|
| gptkbp:mechanismOfAction |
activates natural killer cells
stimulates T-cell proliferation |
| gptkbp:producedBy |
recombinant DNA technology
|
| gptkbp:sideEffect |
gptkb:capillary_leak_syndrome
fever nausea vomiting fatigue chills hypotension |
| gptkbp:usedFor |
renal cell carcinoma
metastatic melanoma |
| gptkbp:bfsParent |
gptkb:Proleukin
|
| gptkbp:bfsLayer |
6
|